Brain

MyndTec Inc. Announces Debt Settlement Agreement with a Director

Mississauga, Ontario--(Newsfile Corp. - August 17, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in…

11 months ago

Ipswich Spine Clinic Receives Rave Reviews for its Transformative Chiropractic Care

Committed to revitalize the age-old treatment technique, Ipswich Spine embodies a patient-centric strategy.SUFFOLK, UK / ACCESSWIRE / August 17, 2023…

11 months ago

Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification

Biostat STR(R) Bioreactor Biostat STR® now contains a fully compatible embedded XCell® ATF hardware and software moduleBioreactor and cell retention…

11 months ago

Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption

Jaguar Health family company Napo Pharmaceuticals focuses on essential supportive care and management of neglected toxicities in multiple complicated disease…

11 months ago

Helius Medical Technologies Announces Reverse Stock Split

NEWTOWN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company…

11 months ago

Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience

Day One receives an exclusive license to develop and commercialize small molecule drug candidates for pediatric and adult cancers with…

11 months ago

FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023

Targeting the Approximate $22 Billion Multiple Sclerosis Drug Treatment MarketTORONTO, ON / ACCESSWIRE / August 15, 2023 / FSD Pharma…

12 months ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

CARMEL, Ind., Aug. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company…

12 months ago

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

The Agreement with a leading full turnkey manufacturer further strengthens the Company's progression towards expected first in human clinical trials…

12 months ago